{"id":"maxomat-biosynthetic-growth-hormone","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Fluid retention"},{"rate":null,"effect":"Carpal tunnel syndrome"},{"rate":null,"effect":"Arthralgia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a recombinant growth hormone, MAXOMAT mimics endogenous human growth hormone by activating GH receptors on target tissues, promoting linear growth in children with growth hormone deficiency, enhancing protein synthesis, and modulating metabolic processes including lipolysis and glucose homeostasis.","oneSentence":"MAXOMAT is a biosynthetic human growth hormone that binds to growth hormone receptors to stimulate growth, metabolism, and protein synthesis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:49:42.397Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Growth hormone deficiency in children"},{"name":"Growth hormone deficiency in adults"}]},"trialDetails":[{"nctId":"NCT04786873","phase":"PHASE3","title":"A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is","status":"COMPLETED","sponsor":"AEterna Zentaris","startDate":"2021-11-16","conditions":"Growth Hormone Deficiency","enrollment":101},{"nctId":"NCT00452725","phase":"PHASE3","title":"Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome","status":"COMPLETED","sponsor":"Sanofi","startDate":"1997-10","conditions":"Noonan Syndrome","enrollment":36},{"nctId":"NCT00452491","phase":"PHASE3","title":"MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal Children","status":"COMPLETED","sponsor":"Sanofi","startDate":"1993-05","conditions":"Fetal Growth Retardation","enrollment":306}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":36,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"MAXOMAT ®, biosynthetic growth hormone","genericName":"MAXOMAT ®, biosynthetic growth hormone","companyName":"Sanofi","companyId":"sanofi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"MAXOMAT is a biosynthetic human growth hormone that binds to growth hormone receptors to stimulate growth, metabolism, and protein synthesis. Used for Growth hormone deficiency in children, Growth hormone deficiency in adults.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}